Insider · CIK 0001546216
Brian Goff
ceoofficerdirector
Files at AGIO (AGIOS PHARMACEUTICALS, INC.), NTLA (Intellia Therapeutics, Inc.). First filing Mar 4, 2025, latest Mar 3, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $2.5M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGIO: AGIOS PHARMACEUTICALS, INC.
AGIOOct 9, 2026 · close 31.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | AGIOS PHARMACEUTICALS, INC. | $523k 18,055 shares | -12% | +31% from low-36% from high | |
| 28Weak | AGIOS PHARMACEUTICALS, INC. | $507k 18,703 shares | -13% | +22% from low-40% from high | |
| 6Weak | AGIOS PHARMACEUTICALS, INC. | $406k 11,085 shares | -8% | +46% from low-42% from high | |
| 30Weak | AGIOS PHARMACEUTICALS, INC. | $627k 18,700 shares | -16% | +36% from low-46% from high | |
| 27Weak | AGIOS PHARMACEUTICALS, INC. | $460k 12,947 shares | -15% | +4% from low-46% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +8,500 | $0.00 | $0 | 151,603 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -3,870 | $28.96 | $112k | 147,733 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +18,000 | $0.00 | $0 | 165,733 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -8,267 | $28.96 | $239k | 157,466 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +13,000 | $0.00 | $0 | 170,466 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -5,918 | $28.96 | $171k | 164,548 | Mar 3, 2026 |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative10b5-1 | +48,000 | $0.00 | $0 | 48,000 | Mar 3, 2026 |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative10b5-1 | +174,000 | $0.00 | $0 | 174,000 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -8,500 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -18,000 | $0.00 | $0 | 18,000 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -13,000 | $0.00 | $0 | 26,000 | Mar 3, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +25,528 | $0.00 | $0 | 149,056 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -12,473 | $27.09 | $338k | 136,583 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +12,750 | $0.00 | $0 | 149,333 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -6,230 | $27.09 | $169k | 143,103 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -25,528 | $0.00 | $0 | 25,528 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -12,750 | $0.00 | $0 | 0 | Jan 2, 2026 |
| Aug 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +22,691 | $0.00 | $0 | 134,613 | Aug 12, 2025 |
| Aug 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -11,085 | $36.67 | $406k | 123,528 | Aug 12, 2025 |
| Aug 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -22,691 | $0.00 | $0 | 0 | Aug 12, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +25,527 | $0.00 | $0 | 117,872 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -12,471 | $33.54 | $418k | 105,401 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +12,750 | $0.00 | $0 | 118,151 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -6,229 | $33.54 | $209k | 111,922 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -25,527 | $0.00 | $0 | 51,056 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -12,750 | $0.00 | $0 | 12,750 | Jun 26, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 23,409 | Jun 13, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 13, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +8,500 | $0.00 | $0 | 87,292 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -4,153 | $35.54 | $148k | 83,139 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +18,000 | $0.00 | $0 | 101,139 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -8,794 | $35.54 | $313k | 92,345 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative10b5-1 | +39,000 | $0.00 | $0 | 39,000 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative10b5-1 | +142,500 | $0.00 | $0 | 142,500 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -8,500 | $0.00 | $0 | 8,500 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -18,000 | $0.00 | $0 | 36,000 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.